'Drug research' presentation slideshows

ZHANG WEI Director General, Department of Drug Registration May 17, 2010, Beijing

Establishment and Implementation of Regulations and Policies on Drug Registration and Impacts on the Pharmaceutical Industry of China. ZHANG WEI Director General, Department of Drug Registration May 17, 2010, Beijing 2 nd DIA China Annual Meeting. Overview.

941 views • 78 slides

THE CHANGING NATURE OF ETHICAL REVIEW Prof. JanHasker G. Jonkman,

THE CHANGING NATURE OF ETHICAL REVIEW Prof. JanHasker G. Jonkman, Ph.D., F.C.P., F.R.Q.A., R.Ph., Clinical Pharmacologist University of Groningen (NL) Professor Quality Management in Drug Research and Manufacturing and. CLINICAL RESEARCH (1).

595 views • 46 slides

Sturla Kristoffer Naas Johansen Consultant RUStelefonen, the national drug helpline in Norway

Sturla Kristoffer Naas Johansen Consultant RUStelefonen, the national drug helpline in Norway. Percentage of young people in Norway aged 15-20 years who say that they have at some time used different drugs 1990-2006. Source: Norwegian Institute for Alcohol and Drug Research.

371 views • 26 slides

Faculty of Science at Strathclyde

406 views • 26 slides

Tracking the Shortfall in TB Research Funding

Tracking the Shortfall in TB Research Funding. Javid Syed Treatment Action Group (TAG). What is Needed?. Global Plan estimates that $9 billion needed from 2006 to 2015 to meet goals rolling back TB levels by 2015 elimination of TB by 2050

330 views • 24 slides

Tracking the Shortfall in TB Research Funding

Tracking the Shortfall in TB Research Funding. Javid Syed Treatment Action Group (TAG). What is Needed?. Global Plan estimates that $9 billion needed from 2006 to 2015 to meet goals rolling back TB levels by 2015 elimination of TB by 2050

245 views • 24 slides

Drug Research and Development (R&D)

394 views • 22 slides

Drug Unit Medicine and Illegal Drugs Ms. Kramer 8 th Grade Health

214 views • 21 slides

Developing and applying integrity policies in a global context

265 views • 16 slides

Adriana Maggi DOCENTE DI BIOTECNOLOGIE FARMACOLOGICHE

Adriana Maggi DOCENTE DI BIOTECNOLOGIE FARMACOLOGICHE CORSO DI LAUREA SPECIALISTICA IN BIOTECNOLOGIE DEL FARMACO Lezione 2. A NOVEL INITIATIVE TO PUT EUROPE AT THE FOREFRONT OF BIOPHARMACEUTICALS INNOVATION. IMI STRATEGIC AGENDA reducing medical needs

282 views • 15 slides

268 views • 9 slides

INSTITUTE OF BIOMEDICAL AND INDUSTRIAL RESEARCH

Institute of Biomedical & Industrial Research (IBIR) is registered under Rajasthan societies act 1958 and approved by Ministry of Environment and Forest, Animal welfare division, Government of India. IBIR is working in the field of preclinical animal studies, preclinical toxicology studies, standardization and development of herbal drug formulation. IBIR is also targeting research in the field of preclinical, toxicology, phytochemical and microbiological screening as well. IBIR is dedicated to discovering and developing innovative cost effective medicine for providing best health care option to society. IBIR is a rising contract research organization which deals in the field of Herbal drugs Formulation development, Pharmacology Studies and Toxicology Studies, Devlop herbal Antimicrobial agents, Phytochemistry of herbal drugs.

291 views • 7 slides

The 9 th Biennial Meeting of the Israeli Chapter of the Controlled Release Society

The 9 th Biennial Meeting of the Israeli Chapter of the Controlled Release Society New trends and technologies in drug delivery and in controlled-release based consumer products. September 9 -11, 2014 Hacienda Forestview Hotel, Maalot Tarshiha , Western Galilee , Israel.

161 views • 2 slides